Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Non-Hodgkin's lymphoma].

Masahiko Oguchi1, Koutaro Gomi, Naoto Shikama

  • 1Department of Radiology, Shinshu University.

Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica
|June 5, 2002
PubMed
Summary

Non-Hodgkin's lymphomas (NHLs) are classified as indolent or aggressive, impacting prognosis and treatment. Radiation therapy and chemotherapy offer survival benefits for early-stage and aggressive NHLs, respectively.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Credentialing of small-field dosimetry for the lung SBRT in Japan Clinical Oncology Group clinical trial.

Journal of applied clinical medical physics·2026
Same author

Multi-institutional study of multileaf collimator parameters and dose calculation accuracy using the enhanced leaf model.

Radiological physics and technology·2026
Same author

Evaluation of the clinical validity of fixation accuracy using an open-face black mask in head stereotactic radiotherapy.

Radiological physics and technology·2026
Same author

A randomized controlled trial of metastasis-directed therapy for oligometastases in breast cancer: OLIGAMI trial (JCOG2110).

Japanese journal of clinical oncology·2026
Same author

Local control of locally advanced uterine sarcoma achieved by cervical brachytherapy with gel spacer following cyclic hypofractionated radiation therapy (QUAD shot) in a patient who refused surgery.

BJR case reports·2026
Same author

Impact of the locking function of hybrid inverse planning optimization on the treatment plan quality of intracavitary/interstitial brachytherapy for locally advanced cervical cancer.

Radiological physics and technology·2026

Area of Science:

  • Hematology
  • Oncology
  • Radiation Oncology

Context:

  • Non-Hodgkin's lymphomas (NHLs) represent a diverse group of lymphoproliferative malignancies originating in lymphoid and extranodal tissues.
  • The WHO classification (2001) stratifies NHLs into indolent and aggressive subtypes, each with distinct clinical behaviors and prognoses.
  • Treatment strategies and outcomes vary significantly based on NHL subtype, stage, and prognostic factors.

Purpose:

  • To outline the classification and prognostic implications of indolent versus aggressive Non-Hodgkin's lymphomas.
  • To describe current treatment modalities, including radiation therapy and chemotherapy (CHOP), for different NHL subtypes and stages.
  • To highlight the role of radiation therapy in localized NHL presentations and the importance of considering long-term adverse reactions.

Summary:

  • Indolent NHLs generally have a favorable prognosis, with potential for high 5-year survival rates using radiation therapy alone in early stages.
  • Aggressive NHLs, despite shorter natural histories, show increasing cure rates with intensive chemotherapy; combined modality treatment improves survival in early stages.
  • Radiation therapy for NHLs involves doses of 25-50 Gy, with field techniques tailored to the involved sites, including extranodal presentations.

Impact:

  • Provides a framework for understanding NHL heterogeneity and guiding treatment decisions.
  • Emphasizes the efficacy of radiation therapy and chemotherapy in improving patient survival for various NHL subtypes.
  • Underscores the need for careful consideration of long-term treatment toxicities in NHL management.

Related Experiment Videos